Charming Medical Ltd (MCTA) stock

MCTAServices-Misc Health & Allied Services, NEC

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 30, 2026Score 3/30

$29.35+0.00 (0.00%)

Close on Nov 5, 2026Market cap $504.17MP/E –Yield –

Charming Medical statistics

82 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Mar 31, 2026
Share price as of: Nov 5, 2026

Valuation ratiosIndustry

Market Cap: $504.17M; $1.68B
Enterprise Value: $499.66M; $2.20B
PS Ratio: 104.87; 1.53
PB Ratio: 97.31; 3.46
P/TBV Ratio: 97.31; 5.80

Enterprise valuationIndustry

EV / Sales: 103.93; 1.67

Share statisticsIndustry

Shares Outstanding: 17M; 59M
Shares Change (YoY): 5.29%; 2.40%
Float: 5M; 34M
Shares Held by Insiders: 71.9%; 15.4%
Shares Held by Institutions: 0.24%; 83.6%

Short sellingIndustry

Short Interest: 552,890; –
Short Interest Change: -3.76%; -0.86%
Short % of Float: 11.5%; 6.28%
Short % of Shares Outstanding: 3.22%; 4.21%
Days to Cover: 999.99; 4.41

Stock price statisticsIndustry

52-Week High: $31.70; –
52-Week Low: $19.01; –
20-Day Moving Average: $29.35; –
50-Day Moving Average: $29.35; –
200-Day Moving Average: $29.35; –
Average True Range (14): $0.00; –
Price Change (1 Week): 0.00%; 0.23%
Price Change (1 Month): -0.02%; -0.02%
Price Change (3 Months): -0.02%; 2.13%
Price Change (6 Months): -0.02%; 17.6%
Price Change (YTD): -0.02%; 5.22%
Price Change (1 Year): 33.3%; 3.75%
Average Volume (10 Days): 0; –
Average Volume (20 Days): 0; –
Average Volume (90 Days): 0; –
Relative Strength Index (14): 0.0; 46.0
Volatility (1 Year): 27.8%; 64.2%

MarginsIndustry

Gross Margin: 99.3%; 33.3%
Operating Margin: -0.61%; -2.98%
Pretax Margin: 2.78%; 2.12%
Profit Margin: -0.47%; -2.01%
EBITDA Margin: -0.61%; 3.36%
FCF Margin: -32.4%; 2.98%

Returns on capitalIndustry

Return on Equity (ROE): -0.87%; 4.82%
Return on Assets (ROA): -0.30%; -3.10%
Return on Invested Capital (ROIC): -13.7%; 4.69%
Return on Capital Employed (ROCE): -0.53%; 0.40%

Financial positionIndustry

Current Ratio: 1.89; 1.41
Quick Ratio: 1.13; 0.99
Debt / Equity: 0.04; 0.68
Interest Coverage: -1.85; -0.63

GrowthIndustry

Revenue Growth (YoY): -22.7%; 9.63%
Net Income Growth (YoY): -101.9%; 16.5%
EPS Growth (YoY): -100.0%; 19.0%
FCF Growth (YoY): -1224.2%; -6.64%

EfficiencyIndustry

Asset Turnover: 0.63; 0.81
Inventory Turnover: 1.34; 10.99
Revenue Per Employee: $165.78K; $235.26K
Profits Per Employee: -$781; -$5.12K
Employee Count: 29; 910

Income statement (TTM)Industry

Revenue: $4.81M; $638.13M
Gross Profit: $4.77M; $196.31M
Operating Income: -$29.24K; -$675.66K
Pretax Income: $133.47K; -$575.82K
Net Income: -$22.65K; -$1.48M
EBITDA: -$29.24K; $1.17M
EPS (Diluted): $0.00; -$0.02

Balance sheetIndustry

Cash & Short-Term Investments: $4.70M; $98.48M
Total Debt: $185.80K; $258.06M
Net Cash (Debt): $4.51M; $203.66K
Net Cash Per Share: $0.26; $0.00
Equity (Book Value): $5.18M; $235.60M
Book Value Per Share: $0.30; $3.91
Tangible Book Value: $5.18M; $1.59M
Working Capital: $3.84M; $30.06M

Cash flow (TTM)Industry

Operating Cash Flow: -$1.22M; $25.90M
Capital Expenditures: -$339.56K; -$15.83M
Free Cash Flow: -$1.56M; $18.83M
FCF Per Share: -$0.09; $0.36

Dividends and yieldsIndustry

Earnings Yield: -0.00%; 0.19%
FCF Yield: -0.31%; 2.55%

Taxes and interestIndustry

Interest Expense: $15.80K; $7.37M
Income Tax: $156.11K; $564.50K
Effective Tax Rate: 117.0%; 24.1%

Scores and fair valueIndustry

Altman Z-Score: 65.49; 2.24
Piotroski F-Score: 2; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 5, 2026. The S&P 500 is measured by the SPY fund.

Period	MCTA	S&P 500	Difference
1 month	-0.0%	-5.4%	+5.4 pts
3 months	-0.0%	-4.5%	+4.5 pts
Year to date	-0.0%	+8.3%	−8.3 pts
1 year	+29.9%	+9.3%	+20.5 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M MCTA shares were sold short on Oct 30, 2026, down 3.8% from the previous report, or 11.45% of the shares available to trade. At recent volumes it would take 1000.0 days to buy them back. Over the last 16 sessions, 37.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Days to cover
Oct 30, 2026	552,890	-3.8%	1000.0
Oct 15, 2026	574,490	-0.0%	1000.0
Sep 30, 2026	574,510	-0.0%	1000.0
Sep 15, 2026	574,770	0.0%	1000.0
Aug 31, 2026	574,770	+0.0%	1000.0
Aug 14, 2026	574,764	0.0%	1000.0
Jul 31, 2026	574,764	-0.2%	1000.0
Jul 15, 2026	575,764	0.0%	1000.0
Jun 30, 2026	575,764	-0.1%	1000.0
Jun 15, 2026	576,264	-16.3%	1000.0
May 29, 2026	688,751	-0.5%	1000.0
May 15, 2026	691,909	-0.4%	1000.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in Charming Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MCTA.

Compare: MCTA vs NIVF · MCTA vs ALPS · MCTA vs PFHO · MCTA vs EUDA · MCTA vs MRAI

Revenue growth-22.7% · median -11.8%

Operating margin-0.6% · median -32.5%

Net margin-0.5% · median -40.4%

Company	Revenue	Growth
MRAI	$17.02M	-17.8%
PFHO	$6.37M	-5.8%
MCTA	$4.81M	-22.7%
NIVF	–	–
ALPS	–	–
EUDA	–	–

Company

Industry: Services-Misc Health & Allied Services, NEC
Employees: 29
Held by institutions: 0.2%
Auditor: WWC, P.C.
SEC CIK: 2035992

Advertisement
300 × 250

See a number that looks wrong?